Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
To compare the clinical efficacy of donepezil between patients with Alzheimer's disease and
 Mixed Dementia.
The purposes of this study are:

 1. to compare the clinical efficacy of donepezil between patients with Alzheimer's disease
 and Mixed Dementia

 2. to help to clinicians in choosing the best treatment for patients with mixed dementia
Inclusion Criteria:

 1. A diagnosis of probable AD and Mixed Dementia according to the criteria of the
 NINCDS-ADRDA

 2. Korean version Mini-Mental State Examination scores between 10 and 26

 3. History of cognitive decline that had been gradual in onset and progressive over at
 least 6 months

 4. A caregiver who could assist the patient with medication, attend the assessment and
 provide information about the patient.

 Exclusion Criteria:

 1. they had evidence of any neurodegenerative diseases other than AD (i.e. Parkinson's
 disease, Huntington's disease)

 2. Psychiatric disorder or severe behavioral disturbances that required psychotropic
 medications

 3. Cerebral injuries induced by trauma, hypoxia, and/or ischemia

 4. Clinically active cerebrovascular disease; History of seizure disorder

 5. Other physical conditions that required acute treatment.